World Intellectual Property Organization

Canada

Patented Medicines (Notice of Compliance) Regulations

Shortcuts

Canada

Year of current version:1993
Date of Text (Issued):March 12, 1993
Type of Text:Implementing Rules/Regulations
Subject Matter:Industrial Property, IP Regulatory Body, Patents (Inventions)
Notes:
This original version of the Patented Medicines (Notice of Compliance) Regulations was last amended on March 25, 2011.

The notification by Canada to the WTO under Article 63.2 of TRIPS states:
The Patented Medicines (Notice of Compliance) Regulations 'allows an innovator to bring an application to prohibit the granting of marketing approval (Notice of Compliance) for a drug, that relies upon the earlier approval of a related drug until all the relevant product and use patents (but not process patents) pertaining to the earlier approved medicine have expired.'
Available Texts: 
English

Patented Medicines (Notice of Compliance) Regulations Patented Medicines (Notice of Compliance) Regulations, Complete document (pdf) [59 KB] Patented Medicines (Notice of Compliance) Regulations, Complete document (htm) [44 KB] (Version with Automatic Translation Tool)

French

Règlement sur les médicaments brevetés(avis de conformité) Règlement sur les médicaments brevetés(avis de conformité), Complete document (pdf) [61 KB]

Related Legislation:
WIPO Lex No.:CA027

Explore WIPO